HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined laser in situ keratomileusis and radial keratotomy for the treatment of moderate to high myopia.

AbstractPURPOSE:
To evaluate the results of combining laser in situ keratomileusis (LASIK) and radial keratotomy (RK) for the correction of moderate to high myopia.
SETTING:
Corneal Consultants of Colorado, Littleton, Colorado, and International Eye Care Laser Vision Center, Houston, Texas, USA.
METHODS:
In a retrospective 2-surgeon interventional case series, outcomes in 60 eyes of 41 patients with moderate to high myopia were reported. All eyes had LASIK using a Visx Star S2 or Summit Apex Plus((R)) excimer laser. Residual myopia was treated with RK.
RESULTS:
Of the 54 eyes corrected for distance, the mean refractive spherical equivalent was -8.09 diopters (D) preoperatively and -0.43 D after LASIK and RK. The mean follow-up was 15.4 months. At the last visit, the uncorrected visual acuity was 20/20 in 22 eyes (41%), 20/25 in 36 eyes (67%), and 20/40 in 51 eyes (94%). No eye lost 2 or more lines of best spectacle-corrected visual acuity.
CONCLUSIONS:
Many patients previously considered poor refractive surgery candidates because of their degree of myopia or corneal thickness could be offered this safe and effective combined refractive technique.
AuthorsRichard E Damiano, Gregory A Kouyoumdjian, S Lance Forstot, Wesley B Kasen, Charles R Moore
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 29 Issue 5 Pg. 908-11 (May 2003) ISSN: 0886-3350 [Print] United States
PMID12781274 (Publication Type: Journal Article)
Topics
  • Adult
  • Cornea (physiopathology, surgery)
  • Female
  • Humans
  • Intraoperative Complications
  • Keratomileusis, Laser In Situ (methods)
  • Keratotomy, Radial (methods)
  • Male
  • Middle Aged
  • Myopia (physiopathology, surgery)
  • Postoperative Complications
  • Refraction, Ocular
  • Retrospective Studies
  • Safety
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: